Results 101 to 110 of about 1,856,875 (191)

Effect of Plasma Soluble Urokinase-Type Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 Levels in the Plasma of Babylon Women with Breast Cancer

Medical Journal of Babylon
Background: Worldwide, the occurrence of breast cancer is elevated as well as the number of mortality in women cancers. The movement of cancer cells from the first stage and invasion of the surrounding tissue are called cancer metastasis.
Sheerin H. Abbas, Zinah Abbass Ali, Alaa Sadiq Alaawad   +2 more
doaj   +1 more source

Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation.

, 2014
Soluble urokinase plasminogen activator receptor (suPAR) in plasma is a novel inflammatory marker thought to be released from the cell surface of neutrophils, T cells, and macrophages.
J. Gustav Smith, Borné, Yan, Smith, Gustav, Olle Melander, Margaretha Persson, Engström, Gunnar, Persson, Margaretha, Gunnar Engström, Yan Borné, Melander, Olle, Persson, Margaretha,, Engström, Gunnar,, Smith, Gustav,, Borné, Yan,, Melander, Olle,, Lund University.   +15 more
core   +2 more sources

Related Article from Urokinase-Type Plasminogen Activator Receptor: A Beacon of Malignancy?

, 2008
Related Article from Urokinase-Type Plasminogen Activator Receptor: A Beacon of ...
Ronny Drapkin (130800), Adam Clauss (14974395), Steven Skates (10033747)   +2 more
core   +1 more source

Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality

, 2013
Patients with decompensated cirrhosis are susceptible to bacterial infections, which are associated with organ failure and a high mortality rate. Reliable biomarkers are needed to identify patients who require intensified treatment.
F. Tacke, Koch, A, Trautwein, C, A. Koch, Zimmermann, H. W., M. Bartneck, Reuken, P A, Zimmermann, H W, Adams, D. H., Adams, David, P. A. Reuken, Bruns, T., Bartneck, M., A. Stallmach, Koch, A., Tacke, F, Tacke, F., Bruns, T, Stallmach, A., H. W. Zimmermann, Bartneck, M, Stallmach, A, D. H. Adams, T. Bruns, Trautwein, C., Reuken, P. A., C. Trautwein   +26 more
core   +1 more source

Tumor markers in breast cancer - European Group on Tumor Markers recommendations [PDF]

, 2005
Recommendations are presented for the routine clinical use of serum and tissue-based markers in the diagnosis and management of patients with breast cancer.
Einarsson, Roland, Barak, Vivian, Dalen, Arie van, Duffy, Michael J., Nap, Marius, Gion, Massimo, Molina, Rafael, Lamerz, Rolf, Sölétormos, György, Goike, Helena, Stieber, Petra   +10 more
core   +1 more source

Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesis [PDF]

, 2010
Background: Squamous cell carcinoma of the head and neck (SCCHN) are highly invasive tumours with frequent local and distant recurrence. Metastasis formation requires degradation of the extracellular matrix, which is fulfilled by membrane-associated ...
Olivier Gires, Muehlenweg Bernd, Pamela Zengel, Muehlenweg, Bernd, Gires, Olivier, Ramp, D., Gires, O., Alexander Berghaus, Gires Olivier, Mack, Brigitte, Zengel, Pamela, Zahler, Stefan, Muehlenweg, B., Diana Ramp, Stefan Zahler, Mack, B., Bernd Muehlenweg, Zahler, S., Berghaus Alexander, Mack Brigitte, Zengel, P., Suna Schmitz, Berghaus, Alexander, Schmitz, Suna, Schmitz, S., Ramp, Diana, Schmitz Suna, Zahler Stefan, Zengel Pamela, Brigitte Mack, Ramp Diana, Berghaus, A.   +31 more
core   +2 more sources

Immunohistochemical staining of urokinase plasminogen activator-like and urokinase plasminogen activator receptor-like proteins in the urinary tract of healthy dogs

, 2006
OBJECTIVE: To determine distribution of urokinase plasminogen activator-like protein and urokinase plasminogen activator receptor-like protein in urinary tract tissues of healthy dogs. ANIMALS: 11 healthy dogs. PROCEDURES: Necropsy specimens from kidney,
Hosgood, Giselle, Bailey, Trina R, Sehgal, Inder, Paulsen, Daniel B   +3 more
core   +1 more source

Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients

, 2020
The novel coronavirus infection has spread worldwide, causing a wide spectrum of clinical manifestations. Most patients develop moderate clinical illness, but a substantial number will experience severe pneumonia, which may rapidly progress to acute ...
Samara, E., Mouzarou, A., Chalkias, A., Pantazopoulos, I., Xanthos, T., Ischaki, E., Chalkias A., Mouzarou A., Samara E., Xanthos T., Ischaki E., Pantazopoulos I.   +6 more
core   +1 more source

A Narrative Review on Abnormalities in the Hemostatic System in Diabetes Mellitus: Pathophysiology, Clinical Implications, and Therapeutics

Life
Diabetes mellitus (DM) is a complex metabolic disorder associated with a heightened risk of cardiovascular events, largely driven by a hypercoagulable and hypofibrinolytic state.
Sana Rafaqat, Hafsa Hamid, Fakhra Bashir, Hijab Abaid, Aleksandra Klisic, Saira Rafaqat, Filiz Mercantepe   +6 more
doaj   +1 more source

Soluble urokinase plasminogen activator receptor across the kidney–cardiometabolic continuum: a systematic review

Frontiers in Immunology
BackgroundSoluble urokinase plasminogen activator receptor (suPAR), a circulating marker of innate immune activation, has been proposed as a risk biomarker in chronic kidney disease (CKD) and related cardiometabolic conditions, but its clinical utility ...
Qishun Wu, Zhiliang Yu, Xin Lin, Ling Yang, Zhangli Wu   +4 more
doaj   +1 more source